Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 11 to 14

A new emotion-regulation and self-monitoring program for teens with overweight or obesity

Official title: Emotion Regulation Intervention to Improve Neural Responsiveness and Health

Run by Texas Tech University · NCT06755827 · Data updated 2026-11-12

This program will test whether weekly emotion-regulation telehealth groups plus mood and behavior self-monitoring help 11–14-year-olds with overweight or obesity better than receiving educational handouts.

More Obese Adolescents trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages11 Years to 14 Years
SexAll
Enrollment30 (estimated)
SponsorTexas Tech University
Academic / other
Locations1 site (Lubbock, Texas)
StatusRecruiting
StartedMarch 24, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 15, 2026
Trial IDNCT06755827 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Teens aged 11–14 who speak English, live in Lubbock County (TX) or nearby, are at or above the 85th BMI percentile, and have internet access for telehealth are the intended participants.

Probably not a fit

Those with psychiatric or medical conditions that interfere with participation, current enrollment in other weight treatments, or MRI contraindications are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Eligible adolescents will be assigned to either a four-week telehealth group program teaching emotion-regulation skills with between-session self-monitoring or to receive educational handouts about overweight and obesity. Participants complete self-report questionnaires, an fMRI scan, and blood draws before and after the intervention to measure neural, biological, and behavioral changes. The trial compares whether the active program reduces cognitive and emotional biases and whether those changes relate to health behaviors and functioning. As a Phase 1/2 pilot, the project focuses on feasibility and preliminary signals to guide future larger trials.

Why it matters

Potential benefit: If successful, the program could improve teens' emotion regulation and self-monitoring in ways that promote healthier behaviors and better weight-related outcomes.

How similar studies have gone: Related emotion-regulation and self-monitoring approaches have shown promise in behavioral studies, but linking neural bias changes to health outcomes in pediatric obesity using fMRI is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being English-proficient
* Ages 11-14
* At or above the 85th BMI percentile based on age and sex norms
* Having access to WIFI or cellular data to attend the telehealth groups
* Living in a home in Lubbock County (TX) or surrounding areas.

Exclusion Criteria:

* Having a psychiatric or medical diagnosis that interferes with participation (e.g., significant developmental delay; pregnancy)
* Current enrollment in overweight/obesity treatment.
* Because the study will include entering an MRI scanner, additional standard exclusion criteria will be considered (e.g., having immovable medical devices with batteries, body piercings on the head/face, and having substantial visual impairment that cannot be corrected with staff-provided glasses)

Where it's running

  • Texas Tech University
    Lubbock, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.